SCHEMBL4758728

SCHEMBL4758728

CCCc1nc2cnc3cc(Br)ccc3c2n1OC(=O)NC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TLR7 Q9NYK1 4/20 0.35
PPARG P37231 2/20 0.33
SCN9A Q15858 1/20 0.33
HTT P42858 2/20 0.33
TSHR P16473 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPK1 P28482 2/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RAB9A P51151 1/20 0.32
GAA P10253 2/20 0.32
RXFP1 Q9HBX9 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4758727 0.80 EGFR (0.38) SMN1; SMN2TLR7PPARGHTTTSHR
SCHEMBL5415670 0.77 PPARG (0.39) SMN1; SMN2LMNAPPARGHTTTSHR
SCHEMBL3863839 0.74 TLR7 (0.46) TLR7PPARGTLR8
SCHEMBL4757052 0.74 HTT (0.33) SMN1; SMN2LMNAPPARGHTTNPSR1
SCHEMBL22336631 0.74 TLR7 (0.40) SMN1; SMN2LMNATLR7CYP2C19EGFR
SCHEMBL4757146 0.73 EGLN2 (0.39) SMN1; SMN2SCN9AMEN1MAPTKMT2A
SCHEMBL4755162 0.73 ATM (0.34) SMN1; SMN2LMNATLR7PPARGHTT
SCHEMBL4757946 0.73 HTT (0.37) LMNAPPARGHTTNPSR1MEN1
SCHEMBL3866782 0.72 TLR7 (0.43) SMN1; SMN2LMNATLR7PPARGTSHR
SCHEMBL23751321 0.72 LMNA (0.36) SMN1; SMN2LMNATLR7NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1605943-A4 1-AMINO 1H-IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES CO (US) 2008-01-16 EP disclosed
EP-1605943-A2 1-AMINO 1H-IMIDAZOQUINOLINES 3M Innovative Properties Company (US) 2005-12-21 EP disclosed
WO-2004080398-A2 1-AMINO 1H-IMIDAZOQUINOLINES 3M INNOVATIVE PROPERTIES COMPANY (US) 2004-09-23 WO disclosed
US-20040176367-A1 1-Amino 1H-imidazoquinolines 3M INNOVATIVE PROPERTIES COMPANY 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176367-A1 1-Amino 1H-imidazoquinolines IL2, IFNG, IL4I1 SMN1; SMN2 2646/4885LMNA 3863/4885L3MBTL1 2918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.